Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Asciminib
Locations
1
United States
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Start Date
February 14, 2025
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2028
Last Updated
February 17, 2026
NCT06658951
NCT07028281
NCT06717750
NCT06737731
NCT07292402
NCT02421380
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions